Sean Brynjelsen, President & CEO at Eton Pharmaceuticals, Inc. (ETON), bought 5,000 shares at $5.96 ($30K) on 2021-06-03, disclosed to the SEC on 2021-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ETON | SELL | 2025-06-05 | $4.8M | — | Filing → |
| ETON | BUY | 2022-09-23 | $21K | — | Filing → |
| ETON | BUY | 2021-08-20 | $43K | — | Filing → |